首页 正文

Proteasome inhibition enhances lysosome-mediated targeted protein degradation

{{output}}
Proteasome inhibitor drugs are currently used in the clinic to treat multiple myeloma and mantle cell lymphoma. These inhibitors cause accumulation of undegraded proteins, thus inducing proteotoxic stress and consequent cell death. However, cancer cells counte... ...